Impact of Glucagon-like Peptide-1 Receptor Agonists on Intestinal Epithelial Cell Barrier
By: Y. Takizawa, A. Kato, A. Onsui, S. Kanatanai, A. Ishimura, T. Kurita and T. Nakajima
Authors
Y. Takizawa
Division of Clinical Pharmaceutics, Department of Pharmaceutical Sciences, Nihon Pharmaceutical University, Saitama, Japan
A. Kato
Division of Clinical Pharmaceutics, Department of Pharmaceutical Sciences, Nihon Pharmaceutical University, Saitama, Japan
A. Onsui
Division of Clinical Pharmaceutics, Department of Pharmaceutical Sciences, Nihon Pharmaceutical University, Saitama, Japan
S. Kanatanai
Division of Clinical Pharmaceutics, Department of Pharmaceutical Sciences, Nihon Pharmaceutical University, Saitama, Japan
A. Ishimura
Division of Practical Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Nihon Pharmaceutical University, Saitama, Japan
T. Kurita
Division of Clinical Pharmaceutics, Department of Pharmaceutical Sciences, Nihon Pharmaceutical University, Saitama, Japan
T. Nakajima
Division of Clinical Pharmaceutics, Department of Pharmaceutical Sciences, Nihon Pharmaceutical University, Saitama, Japan
DOI: https://doi.org/10.2478/afpuc-2024-0008 | Journal eISSN: 2453-6725
Language: English
Page range: 43 - 52
Submitted on: Jan 30, 2024
Accepted on: May 21, 2024
Published on: Aug 7, 2024
Published by: Comenius University in Bratislava, Faculty of Pharmacy
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Related subjects:
© 2024 Y. Takizawa, A. Kato, A. Onsui, S. Kanatanai, A. Ishimura, T. Kurita, T. Nakajima, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.